October 28, 2026—Siemens Healthineers announced the strategic focus of its ultrasound business is shifting to procedural imaging and image-guided therapy. The business will concentrate on cardiovascular interventions, software, artificial intelligence (AI), and partnerships that support physicians in guiding minimally invasive procedures for treatment of cancer, stroke, cardiovascular, and neurodegenerative diseases. According to Siemens, these …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.